Skip to content
Recall Observatory FDA recall evidence

Drug product

Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31

D-0566-2025

July 25, 2025

Class II

Product summary

Firm
Alembic Pharmaceuticals Limited
Event
Event 97323
Status
Ongoing
Classification
Class II
Quantity
9,492 bottles
Official record key
drug-enforcement:D-0566-2025

Official wording

Reason: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

Code information: Lot: 2305015142, Exp. Date: 9/30/2025

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Nitrosamine Drug Substance Related Impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations